DM1 patient muscle biopsy samples where elevated CUGBP1 was observed revealed reduced cyclin D3 levels and increased levels of GSK3β (glycogen synthase kinase 3β, a known negative regulator of cyclin D3) [85]. This evidence concerns the gene GSK3B and myotonic dystrophy type 1.